Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 17, 2026.

Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update

Arif Tasleem Jan

Frontiers in Microbiology · 2017 · Review

doi:10.3389/fmicb.2017.01053

Abstract

Outer Membrane Vesicles (OMVs) of Gram-negative bacteria are spherical membrane-enclosed entities of endocytic origin. Reported in the consortia of different bacterial species, production of OMVs into extracellular milieu seems essential for their survival. Enriched with bioactive proteins, toxins, and virulence factors, OMVs play a critical role in the bacteria-bacteria and bacteria-host interactions. Emergence of OMVs as distinct cellular entities helps bacteria in adaptating to diverse niches, in competing with other bacteria to protect members of producer species and more importantly play a crucial role in host-pathogen interaction. Composition of OMV, their ability to modulate host immune response, along with coordinated secretion of bacterial effector proteins, endows them with the armory, which can withstand hostile environments. Study of the OMV production under natural and diverse stress conditions has broadened the horizons, and also opened new frontiers in delineating the molecular machinery involved in disease pathogenesis. Playing diverse biological and pathophysiological functions, OMVs hold a great promise in enabling resurgence of bacterial diseases, in concomitance with the steep decline in the efficiency of antibiotics. Having multifaceted role, their emergence as a causative agent for a series of infectious diseases increases the probability for their exploitation in the development of effective diagnostic tools and as vaccines against diverse pathogenic species of Gram-negative origin.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

The era of existence of prokaryotes, as autonomous structures has prevailed for a long time. In comparison with the the individual survival traits with few interactions and no compartmentalization, a different group of bacteria has emerged with survival strategies similar to the eukaryotes. With ordered structural organization, fine-tuned physiology, and interactive social behavior, a paradigm shift for better survival is observed in bacteria. Of the differently adapted modes, production of Outer Membrane Vesicles (OMVs) by Gram-negative bacteria, plays a prominent role in interaction among themselves or with the host.

Outer Membrane Vesicles are enriched with proteins that enhance their invasive abilities, thereby promoting efficient internalization of OMVs at the host interface. The best examples include, outer membrane (OM) localized invasins, IpaB, IpaC, and IpaD of Shigella flexneri and Ail protein of Escherichia coli. OM proteins OspA and OspB attribute adhesive properties to OMVs, and thus enhance binding ability of bacteria to host cell receptors. After adherence to host cells, evasion of the host defense system, or the modulation of the host immune responses, is triggered due to the secretion of toxins such as shiga toxin (Stx1 and Stx2), vacuolating toxin (VacA), heat labile toxin (LT), cholera toxin (CT), etc., and virulence factors such as proteases, glycoproteins, etc.. Summary of bacterial OMV production, their properties and functional roles, in bacteria-bacteria and host-bacteria interactions, have been provided in Table 1.

In addition to their role in interspecific competition, release of OMVs greatly enhances the survival scenario for a bacterium by subduing effects of bacteriophages and antimicrobial peptides, during the combat. They also have a role as a signaling molecule, rendering help by abetting inter- and intra-species communication. Despite this, exosome production, loading of cellular components as cargo, conditions that promote their formation and the role it plays under different circumstances, is yet not clearly established. Hitherto, a lacuna in our understanding of the molecular mechanisms for OMV formation, hampers to ascertain their physiological relevance in vivo. In this review, multifaceted aspects of OMV production – their biogenesis, cargo selection and secretory mechanisms, physiological and pathological functions – with respect to the progression of diseases, and possibility of exploiting OMVs in the development of effective diagnostic tools, have been discussed. It is anticipated that the study will broaden our understanding of the OMV biology and will confer new avenues in the use of OMVs for diverse biotechnological applications.

Outer Membrane Vesicles

Outer Membrane Vesicles are small, spherically bilayered (100–300 nm) vesicles released into extracellular milieu from the OM of Gram-negative bacteria. Several bacterial species have been reported to produce OMVs, such as Escherichia coli, Pseudomonas aeruginosa, Shigella sp., Salmonella sp., Helicobacter pylori, Campylobacter jejuni, Borrelia burgdorferi, Vibrio sp., and Neisseria sp. They carry lipopolysaccharides (LPS), phospholipids, peptidoglycan, outer membrane proteins (OMPs), cell wall components, proteins (periplasmic, cytoplasmic, and membrane-bound), nucleic acids (DNA, RNA), ion metabolites and signaling molecules as cargo to them. Owing to the nature of cargo transference, they are anticipated to play a role in the bacterial adherence with the host. They are also involved in stress responses, which involves biofilm formation, inter- and intraspecies delivery of molecules, resistance against antibiotics and modulation of the host immune response.

The ability of OMVs to transfer biological molecules to the host cell, makes their production purposeful among Gram-negative bacteria. Apart from their role in bacterial communication, transfer of virulence factors as cargoes to OMVs, enhances bacterial survival inside the host. The development of secretory systems (I – VI) in Gram-negative bacteria has helped in secretion of virulence factors across the bacterial envelope into the extracellular space. Secreted as distinct entities, OMV mediated transfer of virulence factors, adhesion molecules, toxins and other immunomodulatory compounds, constitutes a separate secretory system, that operates in Gram-negative bacteria to gain access to host tissues and bloodstream.

Production of OMVs

Production of OMVs under in vitro conditions has been reported during the bacterial growth on solid and in liquid media, in biofilms, and also during intracellular infections. As growth conditions have significant influence on the vesiculation process, late grown cells display maximum OMV yields. However, cell death which unavoidably happens during the later stages of the bacterial growth, causes contamination with membrane components and cytosolic proteins. In addition, nutrient unavailability and increased waste disposal at later stages of progressive growth, affects composition profile of OMVs both qualitatively and quantitatively. Representing a mechanism to alleviate stress, factors such as temperature, nutrient depletion and exposure to antibiotics, increases packaging and release of the materials. Given the fact that inside ambience of host cells remains harsh, host-pathogen interactions itself modifies the composition and production of OMVs. In short, changes in the dynamics of OMVs, with regard to the varying nature of its contents during different growth stages, affects their fate and biological functioning.

Biogenesis of OMVs

Maintaining viability during vesicle formation makes process of vesiculation complex and elusive. In light of the evidence generated through various biochemical and genetic studies, several models for the mechanistic production of OMVS have been put forth. Previous studies – by and – on the biogenesis of OMVs suggest that reduction in the cross-linking between peptidoglycan (PG) and OM triggers their formation. As lipoprotein Lpp contributes to OM-PG linkage, it was hypothesized, that hypervesiculation could arise due to a mutation in the lpp gene. vfgl, a different lipoprotein involved in the synthesis and degradation of PG, is associated with OMV production in E. coli (AIEC) and E. coli K12 strain. Contribution of vfgl in OMV production is presumably linked with the increase of PG production or via down-regulation of lytic transglycosylases, which are associated with the maintenance of turgor pressure on OM. Increase in the number of OMVs produced as blebs to OM (Figure 1), relieves cell of the turgor pressure exerted by PG and muramic acid during cell wall synthesis. Although biochemical screening has revealed that OMVs and OM share a similar protein profile, yet, it remains unclear, how cytosolic molecules are packaged to OMVs.

proposed that enrichment of OM with phospholipids, LPS and other specific molecules, brings curvature changes in OM that leads to OMV production. Work done on P. aeruginosa unveils membrane curvature transformations brought by the membrane insertion of a quorum sensing molecule PQS (2-heptyl-3-hydroxy-4-quinolone), results in OMV production. Sequestration of positively charged compounds and destabilization of Mg2+ and Ca2+ salt bridges by PQS, increases anionic repulsion of LPS molecules; thereby increasing OMV production. Enhanced OMV production has been observed by the addition of chelating agents (EDTA), however, addition of Mg2+ to P. aeruginosa results in the antagonist effect. On the contrary, proteins of OM such as OmpA, TolA/B (Tol-Pal), YbgF, and LppAB – which stabilize OM by enhancing protein-protein or protein-PG interactions – also contribute to the biogenesis of OMVs. Moreover, stress such as high temperature, presence of contaminants such as antibiotics also increases OMV production.

Composition of OMVs

Analysis of OMVs, purified by density gradient centrifugation revealed their constituents i-e. proteins and lipids of OM, periplasm, along with different cytoplasmic components. Regarded as distinct cellular entities, following section summarizes the information about the constituents of OMVs, which includes proteins, lipids and other entities:

Proteins

Study of OMVs reveal abundance of OM proteins (OMPs; OmpA, OmpC, and OmpF), periplasmic proteins (AcrA and alkaline phosphatase) and a series of virulence factors involved in the adhesion and invasion of host tissues. With advancements in the MS-based proteomic profiling technologies, identification of more than 3500 proteins – belonging to diverse functional categories – became possible. Evidence suggests that protein cellular localization greatly affects its inclusion to OMVs, as observed for H. pylori and Serratia marcescens. Periplasmic proteins associated with the inner leaflet of OM exhibit increased incorporation within OMVs, in comparison with the proteins that are tightly bound to inner membrane. Although majority of OMPs from H. pylori load as cargo to OMVs, an anomalous behavior in cargo loading behavior in S. marcescens is also observed. In S. marcescens, proteins such as Omps, maltoporin, and TolC, that show abundance on OM, goes undetected in OMVs. Failure in export of MipA in S. marcescens, as a part of OMVs and vice versa, goes unnoticed in the OM. Although, actual mechanism for this mysterious behavior remains elusive, the decision of secretion or cellular retention is believed to occur via a series of protein and lipid recruitment factors. Contrastingly, shiga toxin of S. dysenteriae promotes its secretion by enhancing OMV production. Upholding strain-specific characteristics, preferential packaging of proteins to OMVs is influenced by protein content of OMVs. As packaging process depends on the concentration ratio of OMV with its cellular contents, enrichment of proteins to OMVs occurs when protein contents of OMVs, that are normalized to OM, are significantly higher with respect to their cellular concentration.

Lipids

Lipids represent important structural components of Gram-negative OMVs. Sharing similarity with OM, there are reports of some lipids being present in OMVs but not as part of OM. reported that enterotoxigenic E. coli OMVs have glycerophospholipids, phosphatidylglycerol, phosphatidylethanolamine, and cardiolipin as its major lipids, which are associated with the curvature of OMVs. Chowdhury and Jagannadham, (2013) revealed fine structural characterization of OMVs while performing mass spectrometric (MS) studies on P. syringae. They found, phosphatidylglycerol and phosphatidylethanolamine are the major lipid components in the OMVs. Similarly, other studies also reveal that phosphatidylglycerols are major constituents in OMVs, however, it was also seen that phosphatidylethanolamines compose the major portion of OM. Moreover, higher proportion of saturated fatty acids in OMVs attributes them with a rigid structure.

Performing functions of adhesion in biofilms, LPS (characteristic of Gram negative OM) are also present as component to OMVs. Similar to proteins, only a fractional amount of parent LPS are present in the OMVs. Expressing two types of O-antigen side chains, P. aeruginosa show enrichment of negatively charged B-band forms of LPS in OMVs, compared to neutral A-band. Enrichment of OMVs with B-band LPS is believed to be the consequence of the charge repulsive forces between adjacent B-band molecules in OM. Contrastingly, enrichment with A-band LPS of OMVs has been observed in the dental pathogen, Porphyromonas gingivalis.

Nucleic Acids

Outer Membrane Vesicles carry both luminal and surface associated DNA. A clear distinction between them arises on DNase treatment; luminal DNA being resistant persists even after the treatment process. With this, several different forms of luminal DNA have been reported from E. coli, N. gonorrhoeae, P. aeruginosa, and H. influenza. In addition to DNA, RNA, plasmid and DNA of phage and chromosomal DNA, has also been reported in OMVs. Although actual mechanisms of nucleic acid incorporation remain unclear, but it is believed that nucleic acid incorporation into the interior of OMVs happens from the lysed remains of cells that are present in the milieu, during the process of biogenesis.

Sorting of individual cellular components and their loading as cargo, controls composition and distribution of OMVs, and as such their specificity in counteracting the immune defense system of host. Acting as a signature to bacterial fitness, characteristic enrichment of proteins, lipids and nucleic acids to lumen or localization to OMV membrane, sheds light on the physiological functioning of OMVs and their association in increasing the bacterial survivability in their niche.

Function of OMVs

Outer Membrane Vesicles have characteristics that enable them to mediate transfer of DNA fragments, autolysins, cytotoxins, virulence factors and a variety of other biomolecules. Their secretion helps bacteria in establishing inter- and intra-species communication and also strengthens the interaction with the host. Among the prominent roles in diverse physiological and pathological functions, OMVs have been recognized for their role in acquisition of nutrients, stress responses and delivery of toxins, adhesion and virulence factors to evade host defense system (Figure 2).

Bacterial Mortality and Nutrient Acquisition

Differences in peptidoglycan composition makes bacteria prone to death by OMVs. The killing effect is prominent for bacterial types that show similarity in peptidoglycan composition, as that of OMV donors. Neutralization of bacteria is compromised due to the presence of similar degradative enzymes in OMVs and bacteria, making bacteria less susceptible to degradation. Moreover, fusion of OMVs with a non-self-strain increases their susceptibility toward degradative enzyme machinery. The enzyme cargo of OMVs administers bacteria with the capability of making distinction between self and non-self populations, enabling target specific killing of non-self-bacteria. An excellent example of this system is operational in the Lysobacter sp. – that secretes endopeptidase L5 – which is capable of degrading competing Gram-negative bacteria. A similar mechanism also operates for PG hydrolases. OMVs that possess PG hydrolases produce extermination effects after making a clear distinction for non-self-bacteria.

Of the versatile roles, packaging of enzymes such as proteases and glycosidases as cargoes to OMVs, plays a prominent role in the acquisition of nutrients for bacterial communities. OMV associated DNA and proteins function as a source of carbon and nitrogen during the bacterial growth. OMVs of Myxococcus xanthus carry alkaline phosphatase, which upon act on competitive bacteria cause release of phosphate that promotes development of multicellular community. Phosphoenolpyruvate, a catalytic product of OMVs carrying enolase, converts plasminogen to plasmin. Phosphoenolpyruvate also aids in the bacterial colonization of the host, following the degradation of matrix proteins. The scarcity of metal ions in the bacterial habitats leads to inter- and intra-species competition. In addition to serving as an arsenal in interspecies competition, enrichment of OMVs with rare metal ions makes them available for easy disposal to microbial use.

Stress Response and Biofilm Formation

Mutation in the stress responsive genes increases production of OMVs in the bacteria. Exposure of cells to environmental contaminants (antibiotics) has potentially evolved bacterial OMVs, either with multidrug efflux pumps capabilities or with ability to catalyze degradation by sequestering antibiotics from the extracellular milieu. Acting as nutrient sensors and transporters of essential molecules, enhanced expression of surface receptors and ABC transporter in OMVs increases bacterial survival. The release of unfolded and misfolded proteins to OMVs gives an impression of its development, by sensing a stress responsive state.

Biofilms are surface adhering structures produced in response to stress by bacteria. Matrix assisted biofilms contain polysaccharides, lipids, nucleic acids and protein entities like flagella, pili and OMVs. OMVs mediate delivery of growth factors and components of the extracellular matrix. Release of exopolysaccharides through OMVs increases co-aggregation of cells in the biofilms. Shift from free living to the sedentary state of the bacterial population in biofilms protects cells from desiccation, starvation and adverse effects of antimicrobial agents. Production of OMV helps bacteria to overcome the effects of antimicrobial peptides. Acting as carriage of resistant determinants like β-lactams, and enzymes such as protease, endopeptidases, etc., OMVs give survival advantage to bacteria due to antibiotic resistance traits via biofilms, thereby protects bacteria from antibiotic carnage. Represented as decoy entities, vesicle associated multidrug efflux pumps contribute in transient survival of susceptible bacteria in their surroundings. Association of OMVs with the biofilms of P. aeruginosa has been already reported (, subsequent studies suggest intimidate relation between stress and the production of OMV on observing increase in OMV production during stress conditions.

Secretion of Toxins, Adhesions, and Virulence Factors

Interaction of bacteria with host triggers release of OMVs, carrying proteins (OspA and OspB in B. burgdorferi) and other adhesion molecules (SabA, BabA, and VacA in H. Pylori, UspA1 in M. catarrhalis and aminopeptidase in P. aeruginosa) on their surface. OMVs acting as a bridge to increase adhesion of bacteria with the host tissues. They are also known to increase adherence of bacteria with epithelial linings of gut or the respiratory tract which helps bacteria resist their physical elimination. Association of OMVs with pathogen associated molecular patterns (PAMPs) such as LPS and porins, mediates strong immune response in endothelial cells and induces expression of pattern recognizing receptors on macrophages. OMVs associated toxins such as leukotoxin, LPS, and ClyA are more potent than their soluble forms. Secretion of shiga toxin from enterohemorrhagic E. coli O157:H7 and stx1 and stx2 of S. dysenteriae as cargo to OMVs efficiently inhibits eukaryotic protein synthesis. OMVs harboring multiple virulence factors such as Cif, PlcH, LPS, and alkaline phosphatase produce pronounced effect on host cells. Secretion of toxins and virulence factors help bacteria to invade host cells, hijack host machinery for nutrient acquisition and also evade host defense system by modulating host immune response, which is pivotal for their fecundity and survival in the host.

Invasion of Host and Modulation of Immune Defense

It is well established that OMVs have diverse biological functions i-e. from short range intercellular communications, to their long distance mode of action. They also perform immunomodulatory function by regulating delivery of different constituents to recipient cells. Internalization of OMVs is achieved by four different pathways i-e. Macropinocytosis, Clathrin, Caveolin, and Lipid raft mediated endocytosis. Macropinocytosis is an actin driven process, which allows internalization of OMVs after sampling of extracellular medium at the cell surface. Macropinocytosis is reported from S. flexneri, where it helps to establish infection on host tissues. Clathrin mediated endocytosis via, clathrin coated pits occurs following ligand binding to cell surface receptor, triggering internalization of OVMs. Unlike macropinocytosis that allows internalization of vesicles of 1 μm diameter, clathrin dependent endocytosis allows internalization of cargo, with a maximum of 120nm diameter. Clathrin mediated endocytosis is adapted for internalization of shiga toxin, CT, and cytotoxic virulence factor, VacA of H. pylori. Caveolin mediated endocytosis occurs as cave shaped invagination (80nm) of membrane rich in cholesterol, sphingolipids, and caveolin. Despite sluggish internalization speed (five times less than clathrin mediated), it leads in the efficient delivery of cargo to the cytosol. This type of transfer is utilized by H. influenza. Lipid raft (plasma membrane domains enriched in cholesterol and sphingolipids) mediated endocytosis is known for its involvement in the OMVs entry to host cells. It is hypothesized that clustering of cholesterol rich regions causes curvature in membrane that drives movement of molecules as invagination (90nm) to host cell.

Conclusion

Outer Membrane Vesicles are produced by a series of pathogenic and non-pathogenic bacteria. Devoid of cytosolic components, their cargo content (proteins and lipids) shows high similarity to the OM of the bacteria, from where they originate. Acting as a secretory system, molecules of definite composition destined to different cellular localizations are delivered in an active form, protected by membranous sheath. OMVs are associated with the release of molecules mediating bacterial survival in free state or in biofilm structures, thereby allowing maintenance of virulence, stress release, transformation along with adherence and colonization of bacteria to different hosts. Additionally, they play a significant role in bacterial adaptation by harboring enzymatic machinery for breakdown of complex material into nutrients and consequentially making it available for transportation into cells. With ability to shuttle molecules between cells; they facilitate cell-to-cell communication in a variety of biological processes. Their contribution in processes such as nutrient acquisition, intercellular communication, defense, and regulators of cellular niche has raised considerable interest of scientific fraternity for studying their role as a carrier in the delivery of therapeutics.

Outer Membrane Vesicles are speculated to modulate many physiological and pathological procedures. Exploiting their physiological characteristics, delivery of a series of therapeutic cargos (siRNA, microRNA, and proteins) to tissues has been already achieved. Bioengineering aimed to achieve target specific delivery of therapeutics has also been exploited by designing potent liposomal nanocarriers. With a lipid bilayer topology, encapsulation of amphipathic therapeutics by liposomes, provides them a longer life span, besides increasing their stability with reduced side effects. With maximum use in carrying drugs, liposomal encapsulated chemotherapeutic agents, such as doxorubicin shows its increased accumulation in tumor and significantly reduced toxicity, when compared with the use of free doxorubicin. The facilitation in the release of therapeutic cargo under specific conditions, calls for the bioengineering of liposomes based nanocarriers on the footprints of OMVs, to achieve better targeting and increased uptake of therapeutics.

Author Contributions

AJ conceived the idea and contributed to writing of the manuscript.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 126

  1. 1.

    Alaniz R. C. Deatherage B. L. Lara J. C. Cookson B. T. (2007 ). Membra ne vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179 7692–7701.

    Not in our library10.4049/jimmunol.179.11.7692

  2. 2.

    Allan N. D. Kooi C. Sokol P. A. Beveridge T. J. (2003 ). Putative virulence factors are released in association with membrane vesicles from Burkholderia cepacia. Can. J. Microbiol. 49 613–624.

    Not in our library10.1139/w03-078

  3. 3.

    Altindis E. Fu Y. Mekalanos J. J. (2014 ). Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc. Natl. Acad. Sci. U.S.A. 111 E1548–E1556.

    Not in our library10.1073/pnas.1403683111

  4. 4.

    Bauman S. J. Kuehn M. J. (2006 ). Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 8 2400–2408.

    Not in our library10.1016/j.micinf.2006.05.001

  5. 5.

    Baumgarten T. Sperling S. Seifert J. Von Bergen M. Steiniger F. Wick L. Y. (2012 ). Membrane vesicle formation as a multiple-stress response mechanism enhances Pseudomonas putida DOT-T1E cell surface hydrophobicity and biofilm formation. Appl. Environ. Microbiol. 78 6217–6224.

    Not in our library10.1128/aem.01525-12

  6. 6.

    Bergman M. A. Cummings L. A. Barrett S. L. Smith K. D. Lara J. C. Aderem A. (2005 ). CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect. Immun. 73 1350–1356.

    Not in our library10.1128/iai.73.3.1350-1356.2005

  7. 7.
  8. 8.

    Bernadac A. Gavioli M. Lazzaroni J. C. Raina S. Lloubes R. (1998 ). Escherichia coli tol-pal mutants form outer membrane vesicles. J. Bacteriol. 180 4872–4878.

    Not in our library10.1128/jb.180.18.4872-4878.1998

  9. 9.

    Beveridge T. J. (1999 ). Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181 4725–4733.

    Not in our library10.1128/jb.181.16.4725-4733.1999

  10. 10.

    Beveridge T. J. Makin S. A. Kadurugamuwa J. L. Li Z. (1997 ). Interactions between biofilms and the environment. FEMS Microbiol. Rev. 20 291–303.

    Not in our library10.1111/j.1574-6976.1997.tb00315.x

  11. 11.

    Biller S. J. Schubotz F. Roggensack S. E. Thompson A. W. Summons R. E. Chisholm S. W. (2014 ). Bacterial vesicles in marine ecosystems. Science 343 183–186.

    Not in our library10.1126/science.1243457

  12. 12.

    Bishop A. L. Schild S. Patimalla B. Klein B. Camilli A. (2010 ). Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect. Immun. 78 4402–4420.

    Not in our library10.1128/iai.00398-10

  13. 13.

    Boisvert H. Duncan M. J. (2008 ). Clathrin-dependent entry of a gingipain adhesin peptide and Porphyromonas gingivalis into host cells. Cell Microbiol. 10 2538–2552.

    Not in our library10.1111/j.1462-5822.2008.01228.x

  14. 14.
  15. 15.

    Bonnington K. E. Kuehn M. J. (2014 ). Protein selection and export via outer membrane vesicles. Biochim. Biophys. Acta 1843 1612–1619.

    Not in our library10.1016/j.bbamcr.2013.12.011

  16. 16.

    Burdett I. D. Murray R. G. (1974 ). Electron microscope study of septum formation in Escherichia coli strains B and B-r during synchronous growth. J. Bacteriol. 119 1039–1056.

    Not in our library10.1128/jb.119.3.1039-1056.1974

  17. 17.

    Cascales E. Bernadac A. Gavioli M. Lazzaroni J. C. Lloubes R. (2002 ). Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity. J. Bacteriol. 184 754–759.

    Not in our library10.1128/jb.184.3.754-759.2002

  18. 18.

    Chatterjee D. Chaudhuri K. (2011 ). Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells. FEBS Lett. 585 1357–1362.

    Not in our library10.1016/j.febslet.2011.04.017

  19. 19.

    Chattopadhyay M. K. Jaganandham M. V. (2015 ). Vesicles-mediated resistance to antibiotics in bacteria. Front. Microbiol. 6:758

    Not in our library10.3389/fmicb.2015.00758

  20. 20.

    Chi B. Qi M. Kuramitsu H. K. (2003 ). Role of dentilisin in Treponema denticola epithelial cell layer penetration. Res. Microbiol. 154 637–643.

    Not in our library10.1016/j.resmic.2003.08.001

  21. 21.

    Choi D. S. Kim D. K. Choi S. J. Lee J. Choi J. P. Rho S. (2011 ). Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa. Proteomics 11 3424–3429.

    Not in our library10.1002/pmic.201000212

  22. 22.

    Chowdhury C. Jagannadham M. V. (2013 ). Virulence factors are released in association with outer membrane vesicles of Pseudomonas syringae pv. tomato T1 during normal growth. Biochim. Biophys. Acta 1834 231–239.

    Not in our library10.1016/j.bbapap.2012.09.015

  23. 23.

    Ciofu O. Beveridge T. J. Kadurugamuwa J. Walther-Rasmussen J. Hoiby N. (2000 ). Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45 9–13.

    Not in our library10.1093/jac/45.1.9

  24. 24.

    Collins B. S. (2011 ). Gram-negative outer membrane vesicles in vaccine development. Discov. Med. 12 7–15.

    Not in our library

  25. 25.
  26. 26.

    Devoe I. W. Gilchrist J. E. (1973 ). Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J. Exp. Med. 138 1156–1167.

    Not in our library10.1084/jem.138.5.1156

  27. 27.

    Dorward D. W. Garon C. F. (1989 ). DNA-binding proteins in cells and membrane blebs of Neisseria gonorrhoeae. J. Bacteriol. 171 4196–4201.

    Not in our library10.1128/jb.171.8.4196-4201.1989

  28. 28.

    Dorward D. W. Schwan T. G. Garon C. F. (1991 ). Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans. J. Clin. Microbiol. 29 1162–1170.

    Not in our library10.1128/jcm.29.6.1162-1170.1991

  29. 29.

    Dutta S. Iida K. Takade A. Meno Y. Nair G. B. Yoshida S. (2004 ). Release of Shiga toxin by membrane vesicles in Shigella dysenteriae serotype 1 strains and in vitro effects of antimicrobials on toxin production and release. Microbiol. Immunol. 48 965–969.

    Not in our library10.1111/j.1348-0421.2004.tb03626.x

  30. 30.

    Eddy J. L. Gielda L. M. Caulfield A. J. Rangel S. M. Lathem W. W. (2014 ). Production of outer membrane vesicles by the plague pathogen Yersinia pestis. PLoS ONE 9:e107002

    Not in our library10.1371/journal.pone.0107002

  31. 31.

    Eggert U. S. Ruiz N. Falcone B. V. Branstrom A. A. Goldman R. C. Silhavy T. J. (2001 ). Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. Science 294 361–364.

    Not in our library10.1126/science.1063611

  32. 32.
  33. 33.

    Ellis T. N. Kuehn M. J. (2010 ). Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 74 81–94.

    Not in our library10.1128/mmbr.00031-09

  34. 34.

    Ellis T. N. Leiman S. A. Kuehn M. J. (2010 ). Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect. Immun. 78 3822–3831.

    Not in our library10.1128/iai.00433-10

  35. 35.

    Elmi A. Watson E. Sandu P. Gundogdu O. Mills D. C. Inglis N. F. (2012 ). Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect. Immun. 80 4089–4098.

    Not in our library10.1128/iai.00161-12

  36. 36.

    Evans A. G. Davey H. M. Cookson A. Currinn H. Cooke-Fox G. Stanczyk P. J. (2012 ). Predatory activity of Myxococcus xanthus outer-membrane vesicles and properties of their hydrolase cargo. Microbiology 158 2742–2752.

    Not in our library10.1099/mic.0.060343-0

  37. 37.

    Fernandez-Moreira E. Helbig J. H. Swanson M. S. (2006 ). Membrane vesicles shed by Legionella pneumophila inhibit fusion of phagosomes with lysosomes. Infect. Immun. 74 3285–3295.

    Not in our library10.1128/iai.01382-05

  38. 38.

    Ferrari G. Garaguso I. Adu-Bobie J. Doro F. Taddei A. R. Biolchi A. (2006 ). Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6 1856–1866.

    Not in our library10.1002/pmic.200500164

  39. 39.

    Fiocca R. Necchi V. Sommi P. Ricci V. Telford J. Cover T. L. (1999 ). Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J. Pathol. 188 220–226.

    Not in our library10.1002/(sici)1096-9896(199906)188:2<220::aid-path307>3.0.co;2-c

  40. 40.

    Fulsundar S. Harms K. Flaten G. E. Johnsen P. J. Chopade B. A. Nielsen K. M. (2014 ). Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation. Appl. Environ. Microbiol. 80 3469–3483.

    Not in our library10.1128/aem.04248-13

All 126 references

Cited by papers we hold 24

and 4 more

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.